Drug treatment of multiple sclerosis. Clinical review was unsystematic
Milne, R.; Clegg, A.; Bryant, J.
Bmj 322(7281): 299
2001
ISSN/ISBN: 0959-8138 PMID: 11157552 Document Number: 527008
Document emailed within 1 workday
Related Documents
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68Bergamaschi, R.; Citterio, A.; Filippini, G.; Cosi, V. 1993: Clinical trials in multiple sclerosis: a critical review (1970-1990) Acta Neurologica 15(6): 462-474
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Popova, E.V.; Bryukhov, V.V.; Boyko, A.N.; Krotenkova, M.V.; Konovalova, O.E.; Sharanova, S.N. 2017: Atypical multiple sclerosis - Balo's concentric sclerosis: two case-reports and a review Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 117(2. Vyp. 2): 50-53
Gusev, E.I.; Boĭko, A.N. 2001: Some clinical and medicosocial aspects of new methods of multiple sclerosis pathogenetic treatment Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 101(12): 7-12
Mazzarello, P.; Poloni, M.; Piccolo, G.; Cosi, V.; Pinelli, P. 1983: Intrathecal methylprednisolone acetate in multiple sclerosis treatment. Clinical evaluation Acta Neurologica Belgica 83(4): 190-196
De Haan, R.J.; Polman, C.H. 1996: Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis Nederlands Tijdschrift Voor Geneeskunde 140(44): 2168-2171
Abad, P.; Nogales-Gaete, J.; Rivera, V.; Cristiano, E.; Hamuy, F.; Oehninger, C.; Alvarenga, R.M.P.; Tenembaum, S.; Alarcón-A, T.; Alarcón-G, T.; Cárcamo, C.; Córdova, M.; Díaz, V.; Erazo, R.; Espinosa, E.; Fernández, O.; Garcea, O.; García-Bonitto, J.; Gómez, A.; González-Rabelino, G.; Gracia, F.; Guillén, F.; Hernández, F.; Kleinsteuber, K.; Leiva-Fariñas, R.; León, S.; Macías, M.A.; Narváez, B.; Núñez-Orozco, L.; Paredes, V.; Peña, J.; Peralta, S.; Román, M.; Rubio, E.; Schlatter-Vieira, A.; Soto, A.; Tejada, M.E.; Vélez-Moncada, E. 2012: LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants Revista de Neurologia 55(12): 737-748
Alcala-Vicente, C.; Perez-Miralles, F.C.; Gascon-Gimenez, F.; Bosca-Blasco, I.; Navarre-Gimeno, A.; Coret-Ferrer, F.; Casanova-Estruch, B. 2017: Treatment of relapsing-remitting multiple sclerosis with fingolimod in routine clinical practice Revista de Neurologia 64(10): 445-453
Alonso, K.; Medenica, R. 1995: Immunomodulation in the treatment of multiple sclerosis and amyotrophic lateral sclerosis: a model for autoimmune disorders Journal of the National Medical Association 87(8): 561-568
Ferrante, L.; Mastronardi, L.; Bardella, L. 1986: Acute cerebral multiple sclerosis: importance of a multiple diagnostic approach. Clinical case Rivista di Neurologia 56(6): 347-357
Le Page, E.; Edan, G. 2006: Drug therapy in multiple sclerosis La Revue du Praticien 56(12): 1336-1346
Tourtellotte, W.W.; Syndulko, K.; Baumhefner, R.W.; Shapshak, P.; Osborne, M. 1988: A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase Neurology 38(7 Suppl 2: 83-86
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Freeman, J.W.; Landis, J.; VanDemark, M. 2007: Multiple sclerosis: an essential review South Dakota Medicine: the Journal of the South Dakota State Medical Association 60(6): 231-233; 235
Chong, H.T.; Tan, C.T. 2008: A review of multiple sclerosis with Asian perspective Medical Journal of Malaysia 63(5): 356-361
Kolasa, K. 2013: How much is the cost of multiple sclerosis--systematic literature review Przeglad Epidemiologiczny 67(1): 75-9 157-60
Alonso, A.; Clark, C.J. 2009: Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence Journal of the Neurological Sciences 286(1-2): 73-75